Literature DB >> 19169958

Combining radiation and immunotherapy for synergistic antitumor therapy.

Theresa A Ferrara1, James W Hodge, James L Gulley.   

Abstract

The combination of radiation therapy and immunotherapy holds enticing promise as a strategy for cancer treatment. Preclinical studies have shown that radiation may act synergistically with immunotherapy to enhance or broaden antitumor immune responses, in part, because of radiation-induced phenotypic alterations of tumor cells that render them more susceptible to immune-mediated killing. Clinical trials utilizing the combination of therapeutic vaccines with radiation have supported many of these findings, and other clinical trials are both ongoing and planned. This review examines the evidence that radiation induces immunological death, the mechanisms by which radiation therapy can induce or augment antitumor immune responses, and translational studies demonstrating that immunotherapy can be effectively combined with radiation therapy. Finally, recent and current clinical trials combining radiation therapy with immunotherapy are reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169958      PMCID: PMC3474202     

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  24 in total

Review 1.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.

Authors:  Jason M Grayson; Laurie E Harrington; J Gibson Lanier; E John Wherry; Rafi Ahmed
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

3.  T-cell responses to survivin in cancer patients undergoing radiation therapy.

Authors:  Dörthe Schaue; Begonya Comin-Anduix; Antoni Ribas; Li Zhang; Lee Goodglick; James W Sayre; Annelies Debucquoy; Karin Haustermans; William H McBride
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

4.  Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.

Authors:  Anna K Nowak; Richard A Lake; Amanda L Marzo; Bernadette Scott; William R Heath; Edward J Collins; Jeffrey A Frelinger; Bruce W S Robinson
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

5.  Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy.

Authors:  Dale C Slavin-Chiorini; Marta Catalfamo; Chie Kudo-Saito; James W Hodge; Jeffrey Schlom; Helen Sabzevari
Journal:  Cancer Gene Ther       Date:  2004-10       Impact factor: 5.987

Review 6.  Immunogenic cancer cell death: a key-lock paradigm.

Authors:  Antoine Tesniere; Lionel Apetoh; Francois Ghiringhelli; Nicholas Joza; Theocharis Panaretakis; Oliver Kepp; Frederic Schlemmer; Laurence Zitvogel; Guido Kroemer
Journal:  Curr Opin Immunol       Date:  2008-06-23       Impact factor: 7.486

7.  External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.

Authors:  Mala Chakraborty; Scott I Abrams; C Norman Coleman; Kevin Camphausen; Jeffrey Schlom; James W Hodge
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

8.  The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.

Authors:  Mala Chakraborty; Elizabeth K Wansley; Jorge A Carrasquillo; Sarah Yu; Chang H Paik; Kevin Camphausen; Michael D Becker; William F Goeckeler; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

Review 9.  Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges.

Authors:  James W Hodge; Chandan Guha; Jacques Neefjes; James L Gulley
Journal:  Oncology (Williston Park)       Date:  2008-08       Impact factor: 2.990

10.  Synergistic anti-tumor effect of combination radio- and immunotherapy by electro-gene therapy plus intra-tumor injection of dendritic cells.

Authors:  Yu-Shan Wang; Yuk-Wah Tsang; Chau-Hua Chi; Chao-Chun Chang; Rea-Min Chu; Kwan-Hwa Chi
Journal:  Cancer Lett       Date:  2008-04-07       Impact factor: 8.679

View more
  27 in total

Review 1.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

2.  Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.

Authors:  Lukas W Pfannenstiel; Samuel S K Lam; Leisha A Emens; Elizabeth M Jaffee; Todd D Armstrong
Journal:  Cell Immunol       Date:  2010-03-06       Impact factor: 4.868

3.  Potential synergistic implications for stromal-targeted radiopharmaceuticals in bone-metastatic prostate cancer.

Authors:  Oliver Sartor
Journal:  Asian J Androl       Date:  2011-04-18       Impact factor: 3.285

4.  A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver.

Authors:  James L Gulley; Ravi A Madan; Kwong-Yok Tsang; Philip M Arlen; Kevin Camphausen; Mahsa Mohebtash; Mitchell Kamrava; Jeffrey Schlom; Deborah Citrin
Journal:  Expert Opin Biol Ther       Date:  2011-08-28       Impact factor: 4.388

Review 5.  Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes.

Authors:  Kalpana Mujoo; Clayton R Hunt; Raj K Pandita; Mauro Ferrari; Sunil Krishnan; John P Cooke; Stephen Hahn; Tej K Pandita
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

Review 6.  Immunotherapy in prostate cancer: emerging strategies against a formidable foe.

Authors:  Marijo Bilusic; Christopher Heery; Ravi A Madan
Journal:  Vaccine       Date:  2011-07-07       Impact factor: 3.641

7.  Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer.

Authors:  Daniel W Vermeer; William C Spanos; Paola D Vermeer; Annie M Bruns; Kimberly M Lee; John H Lee
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

Review 8.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

Review 9.  Immunotherapy of cancer.

Authors:  Hossein Borghaei; Mitchell R Smith; Kerry S Campbell
Journal:  Eur J Pharmacol       Date:  2009-10-20       Impact factor: 4.432

Review 10.  Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.

Authors:  Margaret E Gatti-Mays; Jason M Redman; Julie M Collins; Marijo Bilusic
Journal:  Hum Vaccin Immunother       Date:  2017-08-31       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.